Last updated: 23 July 2019 at 6:00am EST

John H Friedman Net Worth




The estimated Net Worth of John H Friedman is at least $11.1 Milión dollars as of 7 November 2013. John Friedman owns over 90,130 units of Cardiovascular Systems stock worth over $3,322,240 and over the last 19 years John sold CSII stock worth over $7,776,275.

John Friedman CSII stock SEC Form 4 insiders trading

John has made over 13 trades of the Cardiovascular Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently John sold 90,130 units of CSII stock worth $2,677,762 on 7 November 2013.

The largest trade John's ever made was selling 90,130 units of Cardiovascular Systems stock on 7 November 2013 worth over $2,677,762. On average, John trades about 24,323 units every 31 days since 2006. As of 7 November 2013 John still owns at least 166,112 units of Cardiovascular Systems stock.

You can see the complete history of John Friedman stock trades at the bottom of the page.



What's John Friedman's mailing address?

John's mailing address filed with the SEC is C/O ACORDA THERAPEUTICS, INC, 15 SKYLINE DRIVE, HAWTHORNE, NY, 10532.

Insiders trading at Cardiovascular Systems

Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor a Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.



What does Cardiovascular Systems do?

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.



Complete history of John Friedman stock trades at Acorda Therapeutics Inc a Cardiovascular Systems

Človek
Trans.
Transakcia
Celková cena
John H Friedman
Riaditeľ
Predaj $2,677,762
7 Nov 2013
John H Friedman
Riaditeľ
Predaj $1,000,699
10 Sep 2013
John H Friedman
Riaditeľ
Predaj $572,029
14 Feb 2012
John H Friedman
Riaditeľ
Predaj $497,797
30 Jan 2012
John H Friedman
Riaditeľ
Predaj $597,379
25 Jan 2012
John H Friedman
Riaditeľ
Predaj $433,111
20 Jan 2012
John H Friedman
Riaditeľ
Predaj $264,205
18 Jan 2012
John H Friedman
Riaditeľ
Predaj $122,213
13 Jan 2012
John H Friedman
Riaditeľ
Predaj $182,859
11 Jan 2012
John H Friedman
Riaditeľ
Predaj $281,340
9 Jan 2012
John H Friedman
Riaditeľ
Predaj $364,267
5 Jan 2012
John H Friedman
Riaditeľ
Predaj $532,364
3 Jan 2012
John H Friedman
Riaditeľ
Predaj $250,250
28 Nov 2011


Cardiovascular Systems executives and stock owners

Cardiovascular Systems executives and other stock owners filed with the SEC include: